Accuracy of hemoglobin A1c imputation using fasting plasma glucose in diabetes research using electronic health records data
Nichols GA, Desai J, Elston Lafata J, Lawrence JM, O'Connor PJ, Pathak R et al. Construction of a multi-site DataLink using electronic health records for the identification, surveillance, prevention, and management of diabetes mellitus: The SUPREME-DM project. Preventing Chron DIs 2012; 9:11_-0311.
Raebel RA, Xu S, Goodrich GK, et al. Predictors of Initial Antihyperglycemic Therapy among Adults with Newly Identified Diabetes in the SUrveillance, PREvention, and ManagEment of Diabetes Mellitus (SUPREME-DM) Cohort. The Annals of Pharmacotherapy. 2013;47(10):1280–1291.
Gonen B, Rachman H, Rubenstein AH, Tanega SP, Horwitz DL. Hemoglobin A1c as an indicator of the degree of glucose intolerance in diabetics. Lancet 1977; 2:734 -737.
Nathan DM, Singer DE, Hurxthal K, Goodson JD. The clinical information value of the glycosylated hemoglobin assay. N Engl J Med 1984; 310:341-346.
Singer DE, Coley CM, Samet JH, Nathan DM. Tests of glycemia in diabetes mellitus: their use in establishing a diagnosis and treatment. Ann Intern Med 1989; 110 :125-137.
The Diabetes Control and Complications Trial Research Group. The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. N Engl J Med. 1993; 329 (14): 977–86.
Diabetes Trials Unit. Oxford University. United Kingdom Prospective Diabetes Study, 1999.
van der Heijden GJ, Donders AR, Stijnen T, Moons KG. Imputation of missing values is superior to complete case analysis and the missing-indicator method in multivariable diagnostic research: a clinical example. J Clin Epidemiol. 2006;59(10):1102-9.
Janssen KJ, Donders AR, Harrell FE Jr, Vergouwe Y, Chen Q, Grobbee DE, Moons KG. Missing covariate data in medical research: to impute is better than to ignore. J Clin Epidemiol 2010;63(7):721-7.
Masica AL, Ewen E, Daoud YA, Cheng D, Franceschini N, Kudyakov RE,
Bowen JR, Brouwer ES, Wallace D, Fleming NS and West SL. Comparative effectiveness research using electronic health records: impacts of oral antidiabetic drugs on the development of chronic kidney disease. Pharmacoepidemiology and Drug Safety 2013 (in press).
Hung AM, Roumie CL, Greevy RA, Liu X, Grijalva CG,Murff HJ, and Griffin MR. Kidney function decline in metformin versus sulfonylurea initiators: assessment of time-dependent contribution of weight, blood pressure, and glycemic control. Pharmacoepidemiology and Drug Safety 2013 (in press).
Rubin DB. Inference and missing data (with discussion). Biometrika 1976; 63:581–592.
The International Expert Committee. International Expert Committee Report on the Role of the A1c Assay in the Diagnosis of Diabetes. Diabetes Care 2009;32:1327–34.
Lu ZX, Walkerm KZ, O'Dea K, Sikaris KA, and Shaw JE. A1C for Screening and Diagnosis of Type 2 Diabetes in Routine Clinical Practice. Diabetes Care 2010; 33: 817-819.
Choi SH, Kim TH, Lim S, Park KS, Jang HC, and Cho NH. Hemoglobin A1c as a Diagnostic Tool for Diabetes Screening and New-Onset Diabetes Prediction: A 6-year community-based prospective study. Diabetes Care 2011; 34(4): 944–949.
Kahn R, Fonseca V. Translating the A1C Assay. Diabetes Care 2008; 31:1-4.
Rohlfing CL, Wiedmeyer HM, Little RR, England JD, Tennill A, Goldstein DE. Defining the relationship between plasma glucose and HbA1c: analysis of glucose profiles and HbA1c in the Diabetes Control and Complications Trial. Diabetes Care 2002; 25:275–278.
Nathan DM, Kuenen J, Borg R, Zheng H, Schoenfeld D, Heine RJ. A1c-Derived Average Glucose Study Group. Translating the A1C assay into estimated average glucose values. Diabetes Care 2008;31(8):1473-8.
American Diabetes Association. Standards of Medical Care in Diabetes-2013. Diabetes Care. 2013 Supplement 1.
Koenig R, Peterson CM, Kilo C, Cerami A, and Williamson JR. Hemoglobin A1c as an indicator of degree of glucose intolerance in diabetes. Diabetes 1976; 25: 230-232.
Little RJ: Regression with missing X's: a review. J Am Stat Assoc 1992; 87:1227-1237.
Little RJ, Rubin DB. Statistical analysis with missing data. New York: Wiley; 2002.
Enders CK. Analyzing structural equation models with missing data. In G. R.Hancock & R. O. Mueller (Eds.), Structural Equation Modeling: A Second Course (pp.313-342). 2006. Greenwich, CT: Information Age Publishing.
White IR, Carlin JB. Bias and efficiency of multiple imputation compared with complete-case analysis for missing covariate values. Stat Med 2010; 29:2920-2931.
Schafer JL. Analysis of Incomplete Multivariate Data. 1997. Chapman and Hall.
Rubin DB. Multiple Imputation for Nonresponse in Surveys. 1987. New York: John Wiley & Sons.
O'Connor PJ, Gregg E, Rush WA, Cherney LM, Stiffman MN, Engelgau MM. Diabetes: how are we diagnosing and initially managing it? Ann Fam Med. 2006;4(1):15-22.
- There are currently no refbacks.